openPR Logo
Press release

Adrenoleukodystrophy Market | Top Impacting Factors To Growth Of The Industry By 2025

Adrenoleukodystrophy Market | Top Impacting Factors To Growth Of The Industry By 2025

Recent research and the current scenario as well as future market potential of Adrenoleukodystrophy Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 – 2025

Adrenoleukodystrophy is also known as Adrenomyeloneuropathy or Schilder-Addison Complex, it is a hereditary condition that damages the myelin sheath (membrane surrounding nerve cells in your brain) and disrupts the breakdown process of long-chain fatty acids (VLCFA). Adrenoleukodystrophy is passed down from parents to their children in a form of X-linked genetic trait. The genetic trait causes deposition of very-long chain fatty acids in the body tissues due to impaired beta oxidation. Myelin sheath in central nervous system, the adrenal cortex and Ledydig cells in the testes are the most severely affected tissues. Adrenoleukodystrophy give rise to three major disease categories such as childhood cerebral form (observed between 4 to 8 years of age), adrenomyelopathy and impaired adrenal gland function (also known as Addison disease).

The major symptoms observed in a childhood cerebral form adrenoleukodystrophy patient are muscle spasms, crossed eyes (strabismus), hearing loss, seizures and other disorders related with the nervous system. In adrenomyelopathy the patients are observed with difficulty in controlling urination, muscle weakness or leg stiffness, difficulties in thinking speed and lack of visual memory. In Addison disease or adrenal gland failure the major symptoms observed are coma, decreased apetite, skin pigmentation, loss of weight, muscle weakness and vomiting. According to Centers for Disease Control and Prevention (CDC), approximately 1 in 20,000 people suffer from X-linked adrenoleukodystrophy. The Office of Rare Diseases (ORD) of the National Institutes of Health (NIH) has listed Adrenoleukodystrophy as a "rare disease". In addition to this, CDC also reported that adrenoleukodystrophy, is a subtype of adrenoleukodystrophy, affects less than 200,000 people in the U.S. population annually.

Get Sample Copy of this report @ www.marketresearchreports.biz/sample/sample/11533

The adrenoleukodystrophy is diagnosed primarily with plasma very long chain fatty acid (VLCFA) examination by application of gas chromatography and/or mass spectrometery. The other diagnostics methods include chromosome studies that are carried out to understand the mutation in ABCD 1 gene and magnetic resonance imaging (MRI) scan of head. Adrenoleukodystrophy is treated with dietary therapy, transplant, adrenal insufficiency and gene therapy. The dietary therapy consists of prohibiting the patient for the intake of very-long chain fatty acids (VLCFA) and this is a supportive therapy to normalize the disease conditions of the patient. The transplants are performed with allogeneic hematopoietic stem cells that assist in the demyelination process where myelin sheath is restored and its deterioration is inhibited. In gene therapy appropriate vectors are selected and modified according to the normal ABCD 1 and later these are transplanted into patient’s bone marrow or stem cell transplant. Adrenal insufficiency is the treatment still under research and trials as this process is ineffective and needs assistance form hormonal replacement therapy. In some cases genetic counseling is recommended for prospective parents with a family history of X-linked adrenoleukodystrophy.

The product pipeline of adrenoleukodystrophy undergoing phase III trials is as follows:

-RPI-78M
-Lenti-D
-Campath-1H + Clofarabine + Melphalan + Hematopoietic Stem Cell Transplantation
-Campath-1H + Cyclophosphamide + Busulfan + Allogeneic Stem Cell Transplantation
-Busulfan + Cyclophosphamide + Antithymocyte Globulin + Hematopoietic Stem Cell Transplantation

North America was observed to be the leading geography followed by Europe due to high prevalence rate, increasing social awareness and key players based in the same geography. Asia-Pacific and Rest of the World lack due to unavailability and inaccessibility of the diagnostic techniques, counseling bodies and modern treatments.

The key players involved in the adrenoleukodystrophy therapeutics market are Nutra Pharma Corporation and GENETIX Pharmaceuticals, Inc. Adrenoleukodystrophy is a rare disease hence the companies involved in therapeutics market of disease are few in number.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

Request For TOC Report @ www.marketresearchreports.biz/sample/toc/11533

The report provides the following information:

-Tailwinds and headwinds molding the market’s trajectory
-Market segments based on products, technology, and applications
-Prospects of each segment
-Overall current and possible future size of the market
-Growth pace of the market
-Competitive landscape and key players’ strategies

The main aim of the report is to:

-Enable key stakeholder’s in the market bet right on it
-Understand the opportunities and pitfalls awaiting them
-Assess the overall growth scope in the near term
-Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.

About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adrenoleukodystrophy Market | Top Impacting Factors To Growth Of The Industry By 2025 here

News-ID: 1717653 • Views: 98

More Releases for Industry VLCFA Addison

Global Dedicated Outdoor Air System (DOAS) Market Status, Industry Players are-M …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Dedicated Outdoor Air System (DOAS) Market Insights, Forecast to 2025” which provides an outlook for current market value as well as the expected growth of Dedicated Outdoor Air System during 2019-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue,
Transportation as a Service (TaaS) Market 2019 - Global Industry Trends (Uber, D …
Transportation as a Service (TaaS) Market 2019 Research report contains a qualified and in-depth examination of Transportation as a Service (TaaS) Market. At first, the report provides an overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. It also covers detailed competitive outlook including the Transportation as a Service (TaaS) market share and company profiles of the key
Boosting factors for Global Addison Disease Testing Market growth, Industry Anal …
This study provides insights about the Addison Disease Testing Market in regards to its uses and benefits. We at Crystal Market Research (CMR) provide updated information that is beneficial in decision making regarding business investments. Competitive Insights The leading players in the market are Diagnostic Laboratory Services, Inc., Any Lab Test Now, Dr Lal PathLabs, Laboratory Corporation of America Holdings and others. The major players in the market are profiled in detail
Silicon Wafers Market 2018 Global Industry Overview by: Renewable Energy, Elkem …
Market Research Future published a research report on “Silicon Wafers Market Research Report- Global Forecast 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Global Silicon Wafers Market - Overview A silicon wafer is a semiconductor material used as a substrate for the fabrication of semiconductor components such as semiconductor ICs. Semiconductor components undergo several micro fabrication steps including ion implantation, etching, deposition of various materials, and